Active SRC expression was found to significantly associate with advanced disease stages, presence of lymph node metastasis, and tumor recurrences in patients with laryngeal tumors, but not in the pharyngeal subgroup. The gene discussed is SRC; the disease is metastatic malignant neoplasm in the lymph nodes.